Crossmark

<scp>COVID</scp> ‐19: lambda interferon against viral load and hyperinflammation

Published Online: 2020-05-25

Published Print: 2020-06-08

Authors

Andreakos, Evangelos https://orcid.org/0000-0001-5536-1661
Tsiodras, Sotirios
Funding

Funding for this research was provided by:

European Commission (779295)

European Commission (767015)

Janssen Pharmaceuticals
License Information

Version of Record valid from 2020-05-25
More Information

Publication History

Published: 2020-05-25

Document is current